S'abonner

Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study - 12/05/21

Doi : 10.1016/j.rmed.2021.106368 
Shahideh Safavi a, b, , Samal Munidasa c, d , Brandon Zanette c , Ruixue Dai e , Elaine Stirrat c , Daniel Li c , Theo J. Moraes c, e , Padmaja Subbarao c, e , Giles Santyr c, d
a Respiratory Medicine Department, School of Medicine, University of Nottingham,Queen's Medical Centre Campus, Nottingham, UK 
b NIHR Nottingham Biomedical Research Centre, Queen's Medical Centre, Nottingham, UK 
c The Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada 
d Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada 
e Division of Respiratory Medicine, Department of Paediatrics, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada 

Corresponding author. Respiratory Medicine Department University of Nottingham School of Medicine Queen's Medical Centre Campus Nottingham NG7 2UH, UK.Respiratory Medicine Department University of Nottingham School of Medicine Queen's Medical Centre Campus Nottingham NG7 2UHUK

Abstract

Introduction

Pulmonary function tests (PFTs) are the main objective measures used to assess asthma in children. However, PFTs provide a global measure of lung function. Hyperpolarised xenon-129 magnetic resonance imaging (129Xe-MRI) can assess lung function spatially. This cross-sectional cohort study aimed to evaluate the use of 129Xe-MRI in detecting ventilation abnormalities in children with well-controlled severe asthma pre- and post-bronchodilator (BD).

Method

Six healthy children (aged 11 ± 3) and six with well-controlled severe asthma (14 ± 1) underwent spirometry, multiple breath washout (MBW), and 129Xe-MRI. These tests were repeated post-BD in the asthma cohort. Image analysis was performed in MATLAB. Wilcoxon signed-rank test, repeated measures analysis of variance (ANOVA), and Spearman's rank correlation coefficient were used for statistical analysis.

Results

A significantly higher number of ventilation defects were found in the asthma cohort pre-BD compared to the healthy participants and post-BD within the asthma cohort (p = 0.02 and 0.01). A greater number of wedge-shaped defects were detected in the asthma cohort pre-BD compared to healthy participants and post-BD within the asthma cohort (p = 0.01 and 0.008, respectively). 129Xe ventilation defect percentage (VDP) and coefficient of variation (CoV) were significantly higher in the asthma cohort pre-BD compared to the healthy cohort (p = 0.006 for both). VDP and CoV were reduced significantly post-BD in the asthma cohort, to a level where there was no longer a significant difference between the two cohorts.

Conclusion

129Xe-MRI is a sensitive marker of ventilation inhomogeneity in paediatric severe asthma and may potentially be used as a biomarker to assess disease progression and therapeutic response.

Le texte complet de cet article est disponible en PDF.

Highlights

129Xe-MRI was feasible in children with severe asthma.
Significant ventilation defects were seen despite well-controlled severe asthma.
Significant reduction in ventilation defects was shown post-bronchodilator.
129Xe-MRI may be more sensitive than LCI and FEV1 at detecting ventilation defects.
129Xe-MRI may be used as an imaging biomarker of therapeutic response.

Le texte complet de cet article est disponible en PDF.

Keywords : 129Xe-MRI, Ventilation defects, Paediatric severe asthma, Bronchodilator response, Lung function


Plan


© 2021  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 180

Article 106368- avril 2021 Retour au numéro
Article précédent Article précédent
  • Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity
  • Matthew Armstrong, Emily Hume, Laura McNeillie, Francesca Chambers, Lynsey Wakenshaw, Graham Burns, Karen Heslop Marshall, Ioannis Vogiatzis
| Article suivant Article suivant
  • Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study
  • Jung Mo Lee, Sang Ah Lee, Chang Hoon Han, Sun Min Lee, Cheong Ju Kim, Sang Chul Lee, Seon Cheol Park

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.